0001807811-23-000001.txt : 20231020 0001807811-23-000001.hdr.sgml : 20231020 20231020100901 ACCESSION NUMBER: 0001807811-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231020 DATE AS OF CHANGE: 20231020 EFFECTIVENESS DATE: 20231020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Interius BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001807811 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-495284 FILM NUMBER: 231336247 BUSINESS ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE STREET 2: BUILDING 200, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19146 BUSINESS PHONE: 215-608-9333 MAIL ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE STREET 2: BUILDING 200, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19146 D 1 primary_doc.xml X0708 D LIVE 0001807811 Interius BioTherapeutics, Inc. 3401 Grays Ferry Ave Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 215-608-9333 DELAWARE None None Corporation true 2019 Philip R. Johnson 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Executive Officer Director Dora Mitchell 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Executive Officer Leon Moulder, Jr. 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Director Benjamin Lund 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Director Tomas Kiselak 3401 Grays Ferry Avenue Building 200, Suite 300 Philadelphia PA PENNSYLVANIA 19146 Director Biotechnology Decline to Disclose 06b false 2023-10-05 false true false 0 21451331 21451331 0 false 13 0 0 0 false Interius BioTherapeutics, Inc. Philip R. Johnson Philip R. Johnson President and CEO 2023-10-20